EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Preoperative Glycosylated Hemoglobin A1C Impacts Long‐Term Outcomes Following Curative‐Intent Resection of Nonfunctional Gastroenteropancreatic Neuroendocrine Tumors

Mu-Xing Li, Alexandra G Lopez-Aguiar, George Poultsides, Flavio Rocha, Sharon Weber, Ryan Fields, Kamran Idrees, Cliff Cho, Shishir K Maithel, Xu-Feng Zhang, Timothy M Pawlik

Journal of Surgical Oncology · 2025

DOI: 10.1002/jso.27951 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Mu-Xing Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Institute of Advanced Surgical Technology and Engineering, The First Affiliated Hospital of Xi'an Jiaotong Unive…. Hauptthemen laut MEDLINE: Glycated Hemoglobin, Neuroendocrine Tumors, Pancreatic Neoplasms, Stomach Neoplasms. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To investigate the impact of preoperative glycosylated hemoglobin A1C (HbA1c) among patients following curative‐intent resection of nonfunctional gastroentropancreatic neuroendocrine tumors (GEP‐NETs).

Methods

Patients who underwent curative‐intent resection for GEP‐NETs from 2000 to 2020 were identified from the US Neuroendocrine Tumor Study Group (US‐NETSG). Preoperative blood HbA1c levels were defined as high HbA1c (≥ 6.5%) versus low HbA1c group (< 6.5%). Impact of HbA1c level on postoperative short‐term and long‐term overall (OS) were investigated.

Results

A total of 130 patients with HbA1c < 6.5% and 60 patients with HbA1c ≥ 6.5% were included. Patients with HbA1c ≥ 6.5% had higher proportion of comorbidities, such as hypertension, obesity, anemia, and lower preoperative albumin levels versus patients with HbA1c < 6.5% (all p < 0.05). In addition, high level of preoperative HbA1c was associated with increased incidence of wound and infectious complications, as well as decreased long‐term OS (median OS: high Hb1Ac 89.8 months vs. low Hb1Ac not reached, HR 3.487, p = 0.004) among patients with nonfunctional GEP‐NETs, as well as among the subset of pancreatic NET patients (median OS: high Hb1Ac 74.3 months vs. low Hb1Ac not reached, p = 0.004), and patients with normal fasting blood glucose (< 140 mg/dL) (median OS: high Hb1Ac 75.4 months vs. low Hb1Ac not reached, p = 0.001).

Conclusions

Hb1Ac might have value as a screening tool to identify high‐risk patients following surgical resection of nonfunctional GEP‐NETs for consideration of more strict postoperative surveillance and treatment of elevated Hb1Ac level.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycated HemoglobinNeuroendocrine TumorsPancreatic NeoplasmsStomach NeoplasmsIntestinal NeoplasmsHumansMaleFemaleMiddle AgedAgedRetrospective StudiesPreoperative PeriodFollow-Up StudiesSurvival RatePrognosisAdult

Stichwörter der Autor:innen

GEP‐NETsHbA1cclinical outcomessurgery

Substanzen

Glycated Hemoglobinhemoglobin A1c protein, human

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, Institute of Advanced Surgical Technology and Engineering, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Department of General Surgery, Peking University Third Hospital, Beijing, China.
  • Department of Surgery, Division of Surgical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
  • Department of Surgery, Stanford University, Palo Alto, California, USA.
  • Department of Surgery, Virginia Mason Medical Center, Seattle, Washington.
  • Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

Zitieren

APA

Li, M. X., Lopez-Aguiar, A. G., Poultsides, G., Rocha, F., Weber, S., Fields, R., Idrees, K., Cho, C., Maithel, S. K., Zhang, X. F., & Pawlik, T. M. (2025). Preoperative Glycosylated Hemoglobin A1C Impacts Long‐Term Outcomes Following Curative‐Intent Resection of Nonfunctional Gastroenteropancreatic Neuroendocrine Tumors. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27951

Vancouver

Li MX, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, et al. Preoperative Glycosylated Hemoglobin A1C Impacts Long‐Term Outcomes Following Curative‐Intent Resection of Nonfunctional Gastroenteropancreatic Neuroendocrine Tumors. Journal of Surgical Oncology. 2025. doi:10.1002/jso.27951

BibTeX
@article{Li2025,
  author = {Li, Mu-Xing and Lopez-Aguiar, Alexandra G and Poultsides, George and Rocha, Flavio and Weber, Sharon and Fields, Ryan and Idrees, Kamran and Cho, Cliff and Maithel, Shishir K and Zhang, Xu-Feng and Pawlik, Timothy M},
  title = {Preoperative Glycosylated Hemoglobin A1C Impacts Long‐Term Outcomes Following Curative‐Intent Resection of Nonfunctional Gastroenteropancreatic Neuroendocrine Tumors},
  journal = {Journal of Surgical Oncology},
  year = {2025},
  doi = {10.1002/jso.27951}
}
Kostenlos starten →